期刊文献+

乳腺癌术后早期辅助化疗的安全性 被引量:15

Safety timing of early postoperative adjuvant chemotherapy in breast cancer
下载PDF
导出
摘要 AIM To investigate the safety timing of immediately postoperative chemotherapy in the patients with breast cancer. METHODS Thirty two patients with breast cancer of classification Ⅱ were admitted to our hospital, were performed on a breast radical resection. The patients were divided randomly into 2 groups and accepted chemotherapy at day 1 (group 1) and day 8 (group 2) after operation respectively, to observe the effect of healing of surgical wound, a response to chemotherapy and a change of IL 2 and sIL 2R lever in serum. RESULTS There were no significant differences between 2 groups in healing of surgical incisions. A few patients in 2 groups felt nausea and vomit but the symptoms were disappeared when they treated based on the correct diagnosis. Also there were no differences between 2 groups on the fall of the number of white blood cells and a similar tend towards in change of IL 2, sIL 2R lever in serum. CONCLUSION Early postoperative adjuvant chemotherapy with better curative effects and fewer side effects durgs will not effect the ability of surgical wound healing and increase the postoperative complications. The immunity function of the body will not depress. A positive effect occurs both on improvement of the 5 year survival rate and on reducing the recurrent rate in patients with breast cancer. AIM To investigate the safety timing of immediately postoperative chemotherapy in the patients with breast cancer. METHODS Thirty two patients with breast cancer of classification Ⅱ were admitted to our hospital, were performed on a breast radical resection. The patients were divided randomly into 2 groups and accepted chemotherapy at day 1 (group 1) and day 8 (group 2) after operation respectively, to observe the effect of healing of surgical wound, a response to chemotherapy and a change of IL 2 and sIL 2R lever in serum. RESULTS There were no significant differences between 2 groups in healing of surgical incisions. A few patients in 2 groups felt nausea and vomit but the symptoms were disappeared when they treated based on the correct diagnosis. Also there were no differences between 2 groups on the fall of the number of white blood cells and a similar tend towards in change of IL 2, sIL 2R lever in serum. CONCLUSION Early postoperative adjuvant chemotherapy with better curative effects and fewer side effects durgs will not effect the ability of surgical wound healing and increase the postoperative complications. The immunity function of the body will not depress. A positive effect occurs both on improvement of the 5 year survival rate and on reducing the recurrent rate in patients with breast cancer.
出处 《第四军医大学学报》 北大核心 2001年第15期1430-1432,共3页 Journal of the Fourth Military Medical University
关键词 乳腺癌 辅助化疗 时机 安全性 breast cancer adjuvant chemotherapy timing
  • 相关文献

参考文献3

  • 1Bang S M,Cancer,2000年,89卷,12期,2521页 被引量:1
  • 2Ling R,细胞与分子免疫学杂志,1997年,13卷,1期,13页 被引量:1
  • 3Han X Z,第四军医大学学报,1996年,17卷,6期,480页 被引量:1

同被引文献76

引证文献15

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部